Search results for "slas europe 2018"

bioMérieux, announces that its VITEK REVEAL AST System, reporting results directly from positive blood cultures, has received US Food and Drug Administration (FDA) 510(k) clearance

CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology

A new study has analyzed roughly 220,000 glaciers

This makes the Oncomine Dx Target Test the first NGS-based companion diagnostic for RET fusion-positive NSCLC and expands the test’s utility

Safe, simple, high performance. The Claisse Eagon 2 fusion instrument is fully automatic. It can process two samples simultaneously and is used to prepare glass disks for XRF analysis. 

Dr. Mimi Roy's commitment to scientific excellence and her work developing gene therapies for rare diseases

Candida auris (C.auris) infections are a major global health challenge, with nosocomial outbreaks on the rise and many strains exhibiting resistance to antifungal agents. New real-time PCR tests enable sensitive and specific identification of the pathogen and of the most important mutations associated with resistance to echinocandins (ECH).

Understand and manage the performance of your automated liquid handlers, multichannel pipettes, labware, operators, and more.

1 vial (2.8E+08 – 4.7E+08 capsids)

Our 2mL crimp top vials are constructed from type 33 and type 51 COE borosilicate glass, with low metal content, to protect your sample from destabilizing or leaching. By choosing our caps and septa, you provide your sample with a the best containment solution available.

Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics

Dr. Timothy Maul discusses the challenges of patient blood management during ECMO and the impact of accurate POC devices for clinical decision making

Your trusted source for online, expert led clinical CE/CPD activities in 2026

Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare settings*

This tool will be launched as part of Roche’s new chronic kidney disease algorithm panel to support care across the stages of the disease which affects 700 million people globally